Ingredients | Amount Per Serving |
---|---|
(Inonotus obliquus, Polysaccharides)
((8:1)(40% Polysaccharides))
|
350 mg |
Vegetable Magnesium Stearate, Silicon Dioxide, Vegetable Hypromellose, Water, Purified
In 2004, Canada began regulating natural medicines as a category of products separate from foods or drugs. These products are officially recognized as "Natural Health Products." These products include vitamins, minerals, herbal preparations, homeopathic products, probiotics, fatty acids, amino acids, and other naturally derived supplements.
In order to be marketed in Canada, natural health products must be licensed. In order to be licensed in Canada, manufacturers must submit applications to Health Canada including information about uses, formulation, dosing, safety, and efficacy.
Products can be licensed based on several criteria. Some products are licensed based on historical or traditional uses. For example, if an herbal product has a history of traditional use, then that product may be acceptable for licensure. In this case, no reliable scientific evidence is required for approval.
For products with non-traditional uses, some level of scientific evidence may be required to support claimed uses. However, a high level of evidence is not necessarily required. Acceptable sources of evidence include at least one well-designed, randomized, controlled trial; well-designed, non-randomized trials; cohort and case control studies; or expert opinion reports.
Finished products licensed by Health Canada must be manufactured according to Good Manufacturing Practices (GMPs) as outlined by Health Canada.
Below is general information about the effectiveness of the known ingredients contained in the product Chaga SAP. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product Chaga SAP. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
There is insufficient reliable information available about the safety of chaga.
PREGNANCY AND LACTATION:
Insufficient reliable information available; avoid using.
Below is general information about the interactions of the known ingredients contained in the product Chaga SAP. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Theoretically, chaga may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
Details
In vitro and animal research suggests that chaga extract can inhibit platelet aggregation (26260). This effect has not been reported in humans.
|
Theoretically, taking chaga with antidiabetes drugs might increase the risk of hypoglycemia.
Details
|
Theoretically, chaga might interfere with immunosuppressive therapy.
Details
In vitro research suggests that certain constituents of chaga stimulate immune function (26263). This has not been reported in humans.
|
Below is general information about the adverse effects of the known ingredients contained in the product Chaga SAP. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General ...There is limited reliable information available regarding the adverse effects of chaga.
Renal ...Orally, there have been two cases of kidney failure and one case of acute nephropathy related to excessive chaga consumption, which contains high concentrations of oxalate (96566,105246,108756).